<i>CHEK2</i>*1100delC Heterozygosity in Women With Breast Cancer Associated With Early Death, Breast Cancer–Specific Death, and Increased Risk of a Second Breast Cancer
Maren Weischer(University of Copenhagen), Annegien Broeks, Frederik Marmé(National Center for Tumor Diseases), Natalia Bogdanova(Medizinische Hochschule Hannover), Fergus J. Couch(WinnMed), Peter A. Fasching(Comprehensive Cancer Center Erlangen), Graham G. Giles(Cancer Council Victoria), Grethe Grenaker Alnæs(University of Copenhagen), Annika Lindblom(Uppsala University), Thilo Dörk(Hannover Re (Germany)), Jonine D. Figueroa, Rob A.�E.�M. Tollenaar, Alison M. Dunning(University of Cambridge), Kamila Czene(Amsterdam UMC Location Vrije Universiteit Amsterdam), Peter Devilee(Leiden University Medical Center), Esther M. John, Irene L. Andrulis(University of New Brunswick), Per Hall(University of Cambridge), Heli Nevanlinna(Helsinki University Hospital), Carl Blomqvist(University of Helsinki), Malcolm Reed(Yorkshire Cancer Research), Vessela N. Kristensen(University of Copenhagen), Alexander Miron(Harvard University), Argyrios Ziogas(University of Copenhagen), Mitul Shah(University of Cambridge), Montserrat García‐Closas(National Cancer Institute), Hoda Anton‐Culver(University of California, Irvine), Diether Lambrechts(KU Leuven), Børge G. Nordestgaard(Herlev Hospital), Paul D.P. Pharoah(Apple (Israel)), Janet E. Olson(Cornell University), Melissa C. Southey(Erasmus MC), Gianluca Severi(Inserm), Julia A. Knight, Taru Muranen(Karolinska Institutet), Qin Wang(University of Cambridge), Johanna Margriet Collée(University of Copenhagen), Barbara Burwinkel(German Cancer Research Center), Matthias W. Beckmann, John L. Hopper(The University of Melbourne), Maartje J. Hooning(University of Copenhagen), Laura J. van’t Veer(Leiden University Medical Center), Veli‐Matti Kosma(University of Eastern Finland), Marie‐Rose Christiaens(University of Copenhagen), Henrik Flyger(Herlev Hospital), Manjeet K. Bolla(University of Cambridge), Richard van Hien(University of Copenhagen), Sara Margolin(University of Copenhagen), Angela Cox
Cited by 180
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k